These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Parotid-gland-sparing 3D conformal radiotherapy in patients with bilateral radiotherapy of the head and neck region--results in clinical practice. Hey J; Setz J; Gerlach R; Janich M; Sehlleier S; Schaller HG; Gernhardt CR; Kuhnt T Oral Oncol; 2009 Feb; 45(2):e11-7. PubMed ID: 18621572 [TBL] [Abstract][Full Text] [Related]
4. A comparison of dose-response models for the parotid gland in a large group of head-and-neck cancer patients. Houweling AC; Philippens ME; Dijkema T; Roesink JM; Terhaard CH; Schilstra C; Ten Haken RK; Eisbruch A; Raaijmakers CP Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1259-65. PubMed ID: 20005639 [TBL] [Abstract][Full Text] [Related]
5. Phenomenologic model describing flow reduction for parotid gland irradiation with intensity-modulated radiotherapy: evidence of significant recovery effect. Scrimger RA; Stavrev P; Parliament MB; Field C; Thompson H; Stavreva N; Fallone BG Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):178-85. PubMed ID: 15337554 [TBL] [Abstract][Full Text] [Related]
6. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy. Dijkema T; Terhaard CH; Roesink JM; Braam PM; van Gils CH; Moerland MA; Raaijmakers CP Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1101-9. PubMed ID: 18472355 [TBL] [Abstract][Full Text] [Related]
7. Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life. Eisbruch A; Dawson LA; Kim HM; Bradford CR; Terrell JE; Chepeha DB; Teknos TN; Anzai Y; Marsh LH; Martel MK; Ten Haken RK; Wolf GT; Ship JA Acta Otorhinolaryngol Belg; 1999; 53(3):271-5. PubMed ID: 10635407 [TBL] [Abstract][Full Text] [Related]
8. [Effect of radiotherapy on the function of the parotid gland]. Simorić S; Sprem N; Voskresensky I; Racić G Laryngol Rhinol Otol (Stuttg); 1987 Sep; 66(9):503-6. PubMed ID: 3683045 [TBL] [Abstract][Full Text] [Related]
9. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study. Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM Laryngoscope; 2009 Oct; 119(10):1966-74. PubMed ID: 19688858 [TBL] [Abstract][Full Text] [Related]
10. The function of the parotid gland following radiation therapy for head and neck cancer. Cheng VS; Downs J; Herbert D; Aramany M Int J Radiat Oncol Biol Phys; 1981 Feb; 7(2):253-8. PubMed ID: 7216860 [No Abstract] [Full Text] [Related]
11. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing. Rosenthal DI; Chambers MS; Weber RS; Eisbruch A Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519 [TBL] [Abstract][Full Text] [Related]
13. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT. Nishimura Y; Nakamatsu K; Shibata T; Kanamori S; Koike R; Okumura M; Suzuki M Jpn J Clin Oncol; 2005 Jul; 35(7):375-9. PubMed ID: 15976068 [TBL] [Abstract][Full Text] [Related]
14. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer. Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418 [TBL] [Abstract][Full Text] [Related]
15. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study. Burlage FR; Roesink JM; Kampinga HH; Coppes RP; Terhaard C; Langendijk JA; van Luijk P; Stokman MA; Vissink A Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):14-22. PubMed ID: 17869018 [TBL] [Abstract][Full Text] [Related]
16. Radiation injury of the parotid glands during treatment for head and neck cancer: assessment using dynamic contrast-enhanced MR imaging. Lee FK; King AD; Kam MK; Ma BB; Yeung DK Radiat Res; 2011 Mar; 175(3):291-6. PubMed ID: 21388272 [TBL] [Abstract][Full Text] [Related]
17. Target coverage for head and neck cancers treated with IMRT: review of clinical experiences. Garden AS; Morrison WH; Rosenthal DI; Chao KS; Ang KK Semin Radiat Oncol; 2004 Apr; 14(2):103-9. PubMed ID: 15095256 [TBL] [Abstract][Full Text] [Related]
18. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy. Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009 [TBL] [Abstract][Full Text] [Related]
19. Sequentially delivered boost plans are superior to simultaneously delivered plans in head and neck cancer when the boost volume is located further away from the parotid glands. Lamers-Kuijper E; Heemsbergen W; van Mourik A; Rasch C Radiother Oncol; 2011 Jan; 98(1):51-6. PubMed ID: 21145606 [TBL] [Abstract][Full Text] [Related]